Portfolio company
ARS Pharmaceuticals
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
ARS Pharmaceuticals develops a needle-free nasal spray for patients and caregivers to treat severe allergic reactions, including anaphylaxis.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Revive Innovations +
This company develops compact, credit-card-sized adrenaline auto-injectors for patients requiring emergency treatment for life-threatening allergic reactions.
Adan Medical
This company develops smart epinephrine autoinjector cases and mobile applications to help patients and public venues manage severe allergic reactions and anaphylaxis.
Alladapt Immunotherapeutics
This biopharmaceutical company develops oral immunotherapies for patients with single or multiple food allergies to reduce the severity of allergic reactions.
Aravax
This clinical-stage pharmaceutical company develops peptide immunotherapies for patients with food allergies, including a lead product for peanut allergy.
ANERGIS SA
Anergis SA develops ultra-fast synthetic vaccines to treat patients suffering from frequent environmental allergies such as birch pollen and house dust mites.
Milestone Pharmaceuticals
This biopharmaceutical company develops and commercialises self-administered nasal sprays for patients suffering from episodic cardiovascular conditions like paroxysmal supraventricular tachycardia.
Moonlight Therapeutics
This biotechnology company develops microneedle dermal stamps that deliver allergen immunotherapy to patients suffering from peanut and other food allergies.
Allergy Amulet
This company manufactures portable sensors for individuals with food allergies to detect specific ingredients and allergens in meals within one minute.
